Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.
- DOI
- 10.1111/dom.70862
- Published
- 2026 Aug
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.70862,
title = {Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.},
author = {Yokote K and Yamauchi T and Fukushima Y and Takatsuka Y and Kato M and Yan S and Inoue T and Borowska L and Brueckmann M and Ogawa W and SYNCHRONIZE‐JP Trial Investigators},
year = {2026},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.70862},
url = {https://doi.org/10.1111/dom.70862}
}RIS
TY - JOUR TI - Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial. AU - Yokote K AU - Yamauchi T AU - Fukushima Y AU - Takatsuka Y AU - Kato M AU - Yan S AU - Inoue T AU - Borowska L AU - Brueckmann M AU - Ogawa W AU - SYNCHRONIZE‐JP Trial Investigators PY - 2026 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.70862 UR - https://doi.org/10.1111/dom.70862 ER -
APA
K, Y., T, Y., Y, F., Y, T., M, K., S, Y., T, I., L, B., M, B., W, O., & Investigators, S. T. (2026). Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70862
Source records
- pubmed · retrieved 2026-09-26T19:04:22.647Z
- europe-pmc · retrieved 2026-09-26T19:04:22.665Z